We found that some modules specifically associated with the clinical characteristics of BRCA2-MUT BC were related to tumor metabolism, cell migration, and other biological functions, and most candidate genes were also expressed in TNBC (Figure 4). The gene discussed is BRCA2; the disease is neoplasm.